These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7262169)

  • 1. Immunological characterization of cell lines establishing from malignant and normal human urothelium.
    Vilien M; Wolf H; Rasmussen F
    Eur J Cancer (1965); 1981 Mar; 17(3):321-7. PubMed ID: 7262169
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 3. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU; Troye M; Paulie S; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity.
    O'Toole CM; Tiptaft RC; Stevens A
    Int J Cancer; 1982 Apr; 29(4):391-5. PubMed ID: 7085129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
    Bloom ET
    Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
    Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
    Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of the bladder.
    Graham SD
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
    Troye M; Perlmann P; Pape GR; Spiegelberg HL; Näslund I; Gidlöf A
    J Immunol; 1977 Sep; 119(3):1061-7. PubMed ID: 302271
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
    Zorzos J; Zizi A; Bakiras A; Pectasidis D; Skarlos DV; Zorzos H; Elemenoglou J; Likourinas M
    Eur Urol; 1995; 28(3):251-4. PubMed ID: 8536781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological detection of an antigen associated with human bladder carcinoma cell lines].
    Tsukahara K
    Nihon Hinyokika Gakkai Zasshi; 1982 Oct; 73(10):1249-58. PubMed ID: 7166918
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
    Troye M; Pape GR
    Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
    Steffens J; Friedmann W; Lobeck H
    Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological reaction to bilharzial carcinoma of urinary bladder.
    Aly MA; el-Makhzangy MI; el-Adl M; Essa MH
    J Egypt Soc Parasitol; 1988 Dec; 18(2):697-703. PubMed ID: 3418166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.